Kronox Lab Sciences has informed that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, January 31, 2025, to consider and approve the Unaudited Standalone Financial Results for the quarter and nine months ended September 30, 2024. The Trading Window for trading in the securities of the Company is closed for Directors, officers, and designated employees of the Company with effective from January 01, 2025, and will continue to remain closed up to 48 hours after declaration of Unaudited Standalone Financial Results of the Company for the quarter and nine months ended December 31, 2024.
The above information is a part of company’s filings submitted to BSE.
